Hyperkalemic renal tubular acidosis induced by trimethoprim/sulfamethoxazole in an AIDS patient.
A patient with the acquired immunodeficiency syndrome (AIDS) and sickle cell anemia presented to the University of Wisconsin Hospital on two separate occasions with pneumocystis carinii pneumonia (PCP). On both occasions he was treated with high-dose intravenous trimethoprim/sulfamethoxazole (TMP/SMX). Several days into each treatment course he developed hyperkalemia and systemic acidosis consistent with hyperkalemic renal tubular acidosis (RTA). The abnormalities resolved in the first instance with the addition of amphotericin B while continuing TMP/SMX, and in the second upon discontinuation of the TMP/SMX. While an increasing number of cases with TMP/SMX-induced hyperkalemia have been reported, hyperkalemic RTA is an uncommon complication of TMP/SMX therapy, occurring in patients with predisposing factors for acidosis such as aldosterone defects, medullary dysfunction and renal insufficiency.
Sheehan
M T
MT
Department of Medicine, University of Wisconsin Center for Health Sciences, Madison, USA.
Wen
S F
SF
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000141:Acidosis, Renal Tubular / Q000139:chemically induced* / Q000175:diagnosis; D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications; D000890:Anti-Infective Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D015497:HIV-1; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy*; D012008:Recurrence; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects*
D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination